NMDA Receptor Antagonism and the Ethanol Intoxication Signal: From Alcoholism Risk to Pharmacotherapy

Annals of the New York Academy of Sciences

Volumn 1003, Issue , 2003, Pages 176-184

  Krystal, John H ^a,b,c   Petrakis, Ismene L ^a,b,c   Krupitsky, Evgeny ^d   Schütz, Christian ^e   Trevisan, Louis ^a,b,c   D'Souza, D Cyril ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Yale University School of Medicine   (United States)

^d PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

Alcohol dependence; Alcoholism; Alcoholism vulnerability; Ethanol; Glutamate; Ketamine; N methyl D aspartate receptor; Pharmacotherapy; Phenotype

Indexed keywords

ACAMPROSATE; ALCOHOL; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CYCLOSERINE; DEXTROMETHORPHAN; GLUTAMATE RECEPTOR; GLYCINE; KETAMINE; LAMOTRIGINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALTREXONE; OPIATE ANTAGONIST; PHENCYCLIDINE;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL TOLERANCE; ALCOHOLISM; BEHAVIOR; CLINICAL TRIAL; CONFERENCE PAPER; CROSS TOLERANCE; DRINKING BEHAVIOR; DYSPHORIA; EUPHORIA; FAMILY HISTORY; HUMAN; NEGATIVE FEEDBACK; PHENOTYPE; PROTEIN FUNCTION; RISK; SENSITIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

EUPHORIA;

EID: 0347722464     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1300.010     Document Type: Conference Paper

References (35)

1. KRYSTAL, J.H., B. TABAKOFF. 2002. Ethanol abuse, dependence, and withdrawal: neurobiology and clinical implications. In Psychopharmacology: A Fifth Generation of Progress. K.L. Davis, D.S. Charney, J.T. Coyle & C. Nemeroff, Eds.: 1425-1443. Lippincott Williams and Wilkins. Philadelphia.
2. GRANT, K.A. & D.M. LOVINGER. 1995. Cellular and behavioral neurobiology of alcohol: receptor-mediated neuronal processes. Clin. Neurosci. 3(3): 155-164.
3. GRANT, K.A. & G. COLOMBO. 1993. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists. J. Pharmacol. Exp. Ther. 264(3): 1241-1247.
4. GRANT, K.A. & G. COLOMBO. 1993. Pharmacological analysis of the mixed discriminative stimulus effects of ethanol. Alcohol Alcohol. Suppl. 2: 445-449.
5. GREEN, K.L. & K.A. GRANT. 1998. Evidence for overshadowing by components of the heterogeneous discriminative stimulus effects of ethanol. Drug Alcohol Depend. 52(2): 149-159.
6. KRYSTAL, J.H., I.L. PETRAKIS, G. MASON, et al. 2003. N-methyl-D- aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol. Ther. 99(1): 79-94.
7. LUBY, E.D., B.D. COHEN, G. ROSENBAUM, et al. 1959. Study of a new schizophrenomimetic drug - sernyl. Arch. Neurol. Psychiatry 81: 363-369.
8. KRYSTAL, J.H., L.P. KARPER, J.P. SEIBYL, et al. 1994. Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51(3): 199-214.
9. KRYSTAL, J.H., I.L. PETRAKIS, E. WEBB, et al. 1998. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch. Gen. Psychiatry 55(4): 354-360.
10. KRUPITSKY, E.M., A.M. BURAKOV, T.N. ROMANOVA, et al. 2001. Attenuation of ketamine effects by nimodipine in recently detoxified ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists. Neuropsychopharmacology 25: 936-947.
11. SCHUTZ, C.G. & M. SOYKA. 2000. Dextromethorphan challenge in alcohol-dependent patients and controls. Arch. Gen. Psychiatry 57(3): 291-292.
12. KRYSTAL, J., I. PETRAKIS, S. KRASNICKI, et al. 1999. Altered responses to agonists of the strychnine-insensitive glycine NMDA coagonist (SIGLY) site in recently detoxified alcoholics. Alcohol. Clin. Exp. Res. 22: 94A.
13. PETRAKIS, I.L., D. LIMONCELLI, R. GUERGUIEVA, et al. 2003. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am. J. Psychiatry. In review.
14. SOYKA, M., B. BONDY, B. EISENBURG & C.G. SCHUTZ. 2000. NMDA receptor challenge with dextromethorphan - subjective response, neuroendocrinological findings and possible clinical implications. J. Neural Transm. 107(6): 701-714.
15. HOFFMAN, P.L. & B. TABAKOFF. 1991. The contribution of voltage-gated and NMDA receptor-gated calcium channels to ethanol withdrawal seizures. Alcohol Alcohol. Suppl. 1: 171-175.
16. TSAI, G. & J.T. COYLE. 1998. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu. Rev. Med. 49: 173-184.
17. KRYSTAL, J.H., I.L. PETRAKIS, D. LIMONCELLI, et al. 2003. Altered NMDA glutamate receptor antagonist response in recovering ethanol dependent patients. Neuropsychopharmacology. In press.
18. SCHUCKIT, M.A. 1985. Ethanol-induced changes in body sway in men at high alcoholism risk. Arch. Gen. Psychiatry 42(4): 375-379.
19. SCHUCKIT, M.A., J.W. TSUANG, R.M. ANTHENELLI, et al. 1996. Alcohol challenges in young men from alcoholic pedigrees and control families: a report from the COGA project. J. Stud. Alcohol 57(4): 368-377.
20. EARLEYWINE, M. 1994. Anticipated biphasic effects of alcohol vary with risk for alcoholism: a preliminary report. Alcohol. Clin. Exp. Res. 18(3): 711-714.
21. ERBLICH, J. & M. EARLEYWINE & B. ERBLICH. 2001. Positive and negative associations with alcohol and familial risk for alcoholism. Psychol. Addict. Behav. 15(3): 204-209.
22. VOLAVKA, J., P. CZOBOR, D.W. GOODWIN, et al. 1996. The electroencephalogram after alcohol administration in high-risk men and the development of alcohol use disorders 10 years later. Arch. Gen. Psychiatry 53(3): 258-263.
23. SCHUCKIT, M.A. & T.L. SMITH. 1996. An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch. Gen. Psychiatry 53(3): 202-210.
24. HOFFMAN, P.L. & B. TABAKOFF. 1996. Alcohol dependence: a commentary on mechanisms. Alcohol Alcohol. 31(4): 333-340.
25. TSAI, G.E., P. RAGAN, R. CHANG, et al. 1998. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am. J. Psychiatry 155(6): 726-732.
26. MALCOLM, R., H. MYRICK, J.S. ROBERTS & R. ANTON. 2000. The effects of lorazepam and carbamazepine on single vs. multiple previous alcohol withdrawals in an outpatient randomized trial. Alcohol. Clin. Exp. Res. 24(5): 38A.
27. MALCOLM, R., H. MYRICK, J. ROBERTS, et al. 2002. The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am. J. Addict. 11(2): 141-150.
28. HOPKINS, J.S., J.C. GARBUTT, C.L. POOLE, et al. 2002. Naltrexone and acamprosate: meta-analysis of two medical treatments for alcoholism. Alcohol. Clin. Exp. Res. 26(5): 130A.
29. MAYER, S., B.R. HARRIS, D.A. GIBSON, et al. Acamprosate, MK-801, and ifenprodil inhibit neurotoxicity and calcium entry induced by ethanol withdrawal in organotypic slice cultures from neonatal rat hippocampus. Alcohol. Clin. Exp. Res. 26(10): 1468-1478.
30. DANYSZ, W., W. DYR, E. JANKOWSKA, et al. 1992. The involvement of NMDA receptors in acute and chronic effects of ethanol. Alcohol. Clin. Exp. Res. 16(3): 499-504.
31. CHESTER, J.A., N.J. GRAHAME, T.K. LI, et al. 2001. Effects of acamprosate on sensitization to the locomotor-stimulant effects of alcohol in mice selectively bred for high and low alcohol preference. Behav. Pharmacol. 12(6-7): 535-543.
32. QUERTEMONT, E., C. BRABANT & P. DE WITTE. 2002. Acamprosate reduces context-dependent ethanol effects. Psychopharmacology 164(1): 10-18.
33. KIEFER, F., H. JAHN, T. TARNASKE, et al. 2003. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch. Gen. Psychiatry 60(1): 92-99.
34. STROMBERG, M.F., S.A. MACKLER, J.R. VOLPICELLI & C.P. O'BRIEN. 2001. Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. Alcohol 23(2): 109-116.
35. SCHÜTZ, C.G., C. MAYER, G. KOLLER, et al. 2002. Combining naltrexone and memantine to block the rewarding effects of alcohol - an experimental pilot study in human subjects. Alcohol. Clin. Exp. Res. 36(5): 130A.